BRAZE INC-A (1BRZE.MI) Fundamental Analysis & Valuation

BIT:1BRZE • US10576N1028

Current stock price

19.4 EUR
-11 (-36.18%)
Last:

This 1BRZE.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1BRZE.MI Profitability Analysis

1.1 Basic Checks

  • 1BRZE had positive earnings in the past year.
  • 1BRZE had a positive operating cash flow in the past year.
  • 1BRZE had negative earnings in each of the past 5 years.
  • In multiple years 1BRZE reported negative operating cash flow during the last 5 years.
1BRZE.MI Yearly Net Income VS EBIT VS OCF VS FCF1BRZE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 2026 0 50M -50M -100M

1.2 Ratios

  • With a Return On Assets value of -11.79%, 1BRZE is not doing good in the industry: 78.99% of the companies in the same industry are doing better.
  • 1BRZE has a worse Return On Equity (-21.05%) than 74.79% of its industry peers.
Industry RankSector Rank
ROA -11.79%
ROE -21.05%
ROIC N/A
ROA(3y)-13.21%
ROA(5y)-14.17%
ROE(3y)-23.99%
ROE(5y)-23.7%
ROIC(3y)N/A
ROIC(5y)N/A
1BRZE.MI Yearly ROA, ROE, ROIC1BRZE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30 -40

1.3 Margins

  • 1BRZE's Gross Margin of 67.15% is in line compared to the rest of the industry. 1BRZE outperforms 40.34% of its industry peers.
  • 1BRZE's Gross Margin has been stable in the last couple of years.
  • 1BRZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y1.05%
1BRZE.MI Yearly Profit, Operating, Gross Margins1BRZE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 2026 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1BRZE.MI Health Analysis

2.1 Basic Checks

  • 1BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 1BRZE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1BRZE has been increased compared to 5 years ago.
  • There is no outstanding debt for 1BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1BRZE.MI Yearly Shares Outstanding1BRZE.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
1BRZE.MI Yearly Total Debt VS Total Assets1BRZE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B

2.2 Solvency

  • 1BRZE has an Altman-Z score of 2.68. This is not the best score and indicates that 1BRZE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1BRZE's Altman-Z score of 2.68 is in line compared to the rest of the industry. 1BRZE outperforms 53.78% of its industry peers.
  • There is no outstanding debt for 1BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.68
ROIC/WACCN/A
WACC10.62%
1BRZE.MI Yearly LT Debt VS Equity VS FCF1BRZE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 2026 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that 1BRZE should not have too much problems paying its short term obligations.
  • 1BRZE has a Current ratio (1.35) which is in line with its industry peers.
  • 1BRZE has a Quick Ratio of 1.35. This is a normal value and indicates that 1BRZE is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BRZE has a Quick ratio (1.35) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
1BRZE.MI Yearly Current Assets VS Current Liabilites1BRZE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. 1BRZE.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 111.11% over the past year.
  • 1BRZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.40%.
  • Measured over the past years, 1BRZE shows a very strong growth in Revenue. The Revenue has been growing by 37.50% on average per year.
EPS 1Y (TTM)111.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)24.4%
Revenue growth 3Y27.59%
Revenue growth 5Y37.5%
Sales Q2Q%27.91%

3.2 Future

  • Based on estimates for the next years, 1BRZE will show a very strong growth in Earnings Per Share. The EPS will grow by 38.96% on average per year.
  • The Revenue is expected to grow by 16.26% on average over the next years. This is quite good.
EPS Next Y69.85%
EPS Next 2Y62.53%
EPS Next 3Y51.93%
EPS Next 5Y38.96%
Revenue Next Year21.43%
Revenue Next 2Y19.16%
Revenue Next 3Y18.4%
Revenue Next 5Y16.26%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1BRZE.MI Yearly Revenue VS Estimates1BRZE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
1BRZE.MI Yearly EPS VS Estimates1BRZE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1BRZE.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 60.62, 1BRZE can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as 1BRZE.
  • The average S&P500 Price/Earnings ratio is at 26.89. 1BRZE is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 35.20, which means the current valuation is very expensive for 1BRZE.
  • 1BRZE's Price/Forward Earnings ratio is in line with the industry average.
  • 1BRZE is valuated expensively when we compare the Price/Forward Earnings ratio to 21.97, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 60.62
Fwd PE 35.2
1BRZE.MI Price Earnings VS Forward Price Earnings1BRZE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 1BRZE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 44.39
EV/EBITDA N/A
1BRZE.MI Per share data1BRZE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • 1BRZE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1BRZE's earnings are expected to grow with 51.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y62.53%
EPS Next 3Y51.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1BRZE.MI Dividend Analysis

5.1 Amount

  • No dividends for 1BRZE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1BRZE.MI Fundamentals: All Metrics, Ratios and Statistics

BRAZE INC-A

BIT:1BRZE (4/17/2026, 7:00:00 PM)

19.4

-11 (-36.18%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-24
Earnings (Next)06-03
Inst Owners75.21%
Inst Owner ChangeN/A
Ins Owners11.1%
Ins Owner ChangeN/A
Market Cap2.20B
Revenue(TTM)738.18M
Net Income(TTM)-131.29M
Analysts85.19
Price Target30.19 (55.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.98%
Min EPS beat(2)-28.83%
Max EPS beat(2)-5.12%
EPS beat(4)2
Avg EPS beat(4)101.81%
Min EPS beat(4)-28.83%
Max EPS beat(4)391.01%
EPS beat(8)6
Avg EPS beat(8)185.33%
EPS beat(12)10
Avg EPS beat(12)138.78%
EPS beat(16)14
Avg EPS beat(16)109.91%
Revenue beat(2)2
Avg Revenue beat(2)1.56%
Min Revenue beat(2)1.48%
Max Revenue beat(2)1.64%
Revenue beat(4)4
Avg Revenue beat(4)1.76%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.31%
Revenue beat(12)12
Avg Revenue beat(12)1.8%
Revenue beat(16)16
Avg Revenue beat(16)2.02%
PT rev (1m)-25.89%
PT rev (3m)-25.89%
EPS NQ rev (1m)-10.2%
EPS NQ rev (3m)-10.2%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)4.15%
Revenue NQ rev (3m)4.15%
Revenue NY rev (1m)3.51%
Revenue NY rev (3m)3.51%
Valuation
Industry RankSector Rank
PE 60.62
Fwd PE 35.2
P/S 3.49
P/FCF 44.39
P/OCF 36.08
P/B 4.13
P/tB 8.58
EV/EBITDA N/A
EPS(TTM)0.32
EY1.65%
EPS(NY)0.55
Fwd EY2.84%
FCF(TTM)0.44
FCFY2.25%
OCF(TTM)0.54
OCFY2.77%
SpS5.56
BVpS4.69
TBVpS2.26
PEG (NY)0.87
PEG (5Y)N/A
Graham Number5.81379 (-70.03%)
Profitability
Industry RankSector Rank
ROA -11.79%
ROE -21.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.15%
FCFM 7.87%
ROA(3y)-13.21%
ROA(5y)-14.17%
ROE(3y)-23.99%
ROE(5y)-23.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y1.05%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 69.14%
Cap/Sales 1.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 2.68
F-Score4
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)143.07%
Cap/Depr(5y)189.8%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)111.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y69.85%
EPS Next 2Y62.53%
EPS Next 3Y51.93%
EPS Next 5Y38.96%
Revenue 1Y (TTM)24.4%
Revenue growth 3Y27.59%
Revenue growth 5Y37.5%
Sales Q2Q%27.91%
Revenue Next Year21.43%
Revenue Next 2Y19.16%
Revenue Next 3Y18.4%
Revenue Next 5Y16.26%
EBIT growth 1Y-9.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year225.57%
EBIT Next 3Y94.06%
EBIT Next 5Y66.54%
FCF growth 1Y195.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.76%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZE INC-A / 1BRZE.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BRAZE INC-A (1BRZE.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1BRZE.MI.


Can you provide the valuation status for BRAZE INC-A?

ChartMill assigns a valuation rating of 3 / 10 to BRAZE INC-A (1BRZE.MI). This can be considered as Overvalued.


What is the profitability of 1BRZE stock?

BRAZE INC-A (1BRZE.MI) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for 1BRZE stock?

The Price/Earnings (PE) ratio for BRAZE INC-A (1BRZE.MI) is 60.62 and the Price/Book (PB) ratio is 4.13.


How financially healthy is BRAZE INC-A?

The financial health rating of BRAZE INC-A (1BRZE.MI) is 6 / 10.